Literature DB >> 29430990

The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Tobias Brummer1,2, Martina Pigoni1,2, Armando Rossello3, Huanhuan Wang1,4, Peter J Noy5, Michael G Tomlinson5, Carl P Blobel6,7,8,9, Stefan F Lichtenthaler1,2,9,10.   

Abstract

The transmembrane protein, ADAM10 (a disintegrin and metalloprotease 10), has key physiologic functions-for example, during embryonic development and in the brain. During transit through the secretory pathway, immature ADAM10 (proADAM10) is converted into its proteolytically active, mature form (mADAM10). Increasing or decreasing the abundance and/or activity of mADAM10 is considered to be a therapeutic approach for the treatment of such diseases as Alzheimer's disease and cancer. Yet biochemical detection and characterization of mADAM10 has been difficult. In contrast, proADAM10 is readily detected-for example, in immunoblots-which suggests that mADAM10 is only a fraction of total cellular ADAM10. Here, we demonstrate that mADAM10, but not proADAM10, unexpectedly undergoes rapid, time-dependent degradation upon biochemical cell lysis in different cell lines and in primary neurons, which prevents the detection of the majority of mADAM10 in immunoblots. This degradation required the catalytic activity of ADAM10, was efficiently prevented by adding active site inhibitors to the lysis buffer, and did not affect proADAM10, which suggests that ADAM10 degradation occurred in an intramolecular and autoproteolytic manner. Inhibition of postlysis autoproteolysis demonstrated efficient cellular ADAM10 maturation with higher levels of mADAM10 than proADAM10. Moreover, a cycloheximide chase experiment revealed that mADAM10 is a long-lived protein with a half-life of approximately 12 h. In summary, our study demonstrates that mADAM10 autoproteolysis must be blocked to allow for the proper detection of mADAM10, which is essential for the correct interpretation of biochemical and cellular studies of ADAM10.-Brummer, T., Pigoni, M., Rossello, A., Wang, H., Noy, P. J., Tomlinson, M. G., Blobel, C. P., Lichtenthaler, S. F. The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Entities:  

Keywords:  ADAM17; Alzheimer’s; GI254023X; NrCAM; tetraspanin15

Mesh:

Substances:

Year:  2018        PMID: 29430990      PMCID: PMC5998973          DOI: 10.1096/fj.201700823RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  66 in total

1.  The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex.

Authors:  Ellen Jorissen; Johannes Prox; Christian Bernreuther; Silvio Weber; Ralf Schwanbeck; Lutgarde Serneels; An Snellinx; Katleen Craessaerts; Amantha Thathiah; Ina Tesseur; Udo Bartsch; Gisela Weskamp; Carl P Blobel; Markus Glatzel; Bart De Strooper; Paul Saftig
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

Review 2.  The metalloproteinase ADAM10: A useful therapeutic target?

Authors:  Sebastian Wetzel; Lisa Seipold; Paul Saftig
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-06-15       Impact factor: 4.739

3.  Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.

Authors:  Emanuela Pasciuto; Tariq Ahmed; Tina Wahle; Fabrizio Gardoni; Laura D'Andrea; Laura Pacini; Sébastien Jacquemont; Flora Tassone; Detlef Balschun; Carlos G Dotti; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Ulrike C Müller; Monica Di Luca; Bart De Strooper; Claudia Bagni
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

4.  Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.

Authors:  Tom C M Seegar; Lauren B Killingsworth; Nayanendu Saha; Peter A Meyer; Dhabaleswar Patra; Brandon Zimmerman; Peter W Janes; Eric Rubinstein; Dimitar B Nikolov; Georgios Skiniotis; Andrew C Kruse; Stephen C Blacklow
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

5.  Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease.

Authors:  Roberta Epis; Elena Marcello; Fabrizio Gardoni; Csaba Vastagh; Matteo Malinverno; Claudia Balducci; Alessio Colombo; Barbara Borroni; Hugo Vara; Mario Dell'Agli; Flamino Cattabeni; Maurizio Giustetto; Tiziana Borsello; Gianluigi Forloni; Alessandro Padovani; Monica Di Luca
Journal:  Brain       Date:  2010-08-30       Impact factor: 13.501

6.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Authors:  Christian Hundhausen; Dominika Misztela; Theo A Berkhout; Neil Broadway; Paul Saftig; Karina Reiss; Dieter Hartmann; Falk Fahrenholz; Rolf Postina; Vance Matthews; Karl-Josef Kallen; Stefan Rose-John; Andreas Ludwig
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

7.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

8.  Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.

Authors:  Alessio Colombo; Huanhuan Wang; Peer-Hendrik Kuhn; Richard Page; Elisabeth Kremmer; Peter J Dempsey; Howard C Crawford; Stefan F Lichtenthaler
Journal:  Neurobiol Dis       Date:  2012-08-24       Impact factor: 5.996

Review 9.  Scissor sisters: regulation of ADAM10 by the TspanC8 tetraspanins.

Authors:  Alexandra L Matthews; Justyna Szyroka; Richard Collier; Peter J Noy; Michael G Tomlinson
Journal:  Biochem Soc Trans       Date:  2017-06-15       Impact factor: 5.407

10.  TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.

Authors:  Emmanuel Dornier; Franck Coumailleau; Jean-François Ottavi; Julien Moretti; Claude Boucheix; Philippe Mauduit; François Schweisguth; Eric Rubinstein
Journal:  J Cell Biol       Date:  2012-10-22       Impact factor: 10.539

View more
  11 in total

Review 1.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

2.  The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex.

Authors:  Chek Ziu Koo; Neale Harrison; Peter J Noy; Justyna Szyroka; Alexandra L Matthews; Hung-En Hsia; Stephan A Müller; Johanna Tüshaus; Joelle Goulding; Katie Willis; Clara Apicella; Bethany Cragoe; Edward Davis; Murat Keles; Antonia Malinova; Thomas A McFarlane; Philip R Morrison; Hanh T H Nguyen; Michael C Sykes; Haroon Ahmed; Alessandro Di Maio; Lisa Seipold; Paul Saftig; Eleanor Cull; Christos Pliotas; Eric Rubinstein; Natalie S Poulter; Stephen J Briddon; Nicholas D Holliday; Stefan F Lichtenthaler; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2020-02-28       Impact factor: 5.157

3.  Autophagy-Dependent Increased ADAM10 Mature Protein Induced by TFEB Overexpression Is Mediated Through PPARα.

Authors:  Hongjie Wang; Mohan Kumar Muthu Karuppan; Madhavan Nair; Madepalli K Lakshmana
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

4.  Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury in Mice.

Authors:  Dominik Appel; Regina Hummel; Martin Weidemeier; Kristina Endres; Christina Gölz; Michael K E Schäfer
Journal:  Front Cell Dev Biol       Date:  2021-03-15

5.  Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.

Authors:  Tomaž Žagar; Miha Pavšič; Aljaž Gaber
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

6.  Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotype.

Authors:  Jose Lora; Gisela Weskamp; Thomas M Li; Thorsten Maretzky; Dorjee T N Shola; Sébastien Monette; Stefan F Lichtenthaler; Theresa T Lu; Chingwen Yang; Carl P Blobel
Journal:  J Biol Chem       Date:  2021-05-03       Impact factor: 5.157

7.  NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.

Authors:  Tobias Brummer; Stephan A Müller; Francisco Pan-Montojo; Fumiaki Yoshida; Andreas Fellgiebel; Taisuke Tomita; Kristina Endres; Stefan F Lichtenthaler
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

8.  Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.

Authors:  Simone D Scilabra; Martina Pigoni; Veronica Pravatá; Tobias Schätzl; Stephan A Müller; Linda Troeberg; Stefan F Lichtenthaler
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

9.  The metalloproteinase ADAM10 requires its activity to sustain surface expression.

Authors:  Anke Seifert; Stefan Düsterhöft; Justyna Wozniak; Chek Z Koo; Michael G Tomlinson; Elisa Nuti; Armando Rossello; Doretta Cuffaro; Daniela Yildiz; Andreas Ludwig
Journal:  Cell Mol Life Sci       Date:  2020-05-05       Impact factor: 9.261

10.  shRNAs targeting mouse Adam10 diminish cell response to proinflammatory stimuli independently of Adam10 silencing.

Authors:  Maria Czarnek; Krystyna Stalińska; Katarzyna Sarad; Joanna Bereta
Journal:  Biol Open       Date:  2022-03-04       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.